Integra LifeSciences has acquired Tornier's Salto Talaris and Salto Talaris XT ankle replacement products as well as Tornier's Futura silastic toe replacement products.
Here are five key notes:
1. The Salto Talaris products aim to provide accuracy and reproducibility with precision instrumentation.
2. The Futura products utilize UltraSIL, a fourth generation silicone polymer, which has high tensile strength and tear and abrasion resistance.
3. During the first 12 months, Integra expects the contribution of the acquisition to adjusted earnings per share to be immaterial.
4. Wright Medical Group recently merged with Tornier. However, before the merger was finalized, the Federal Trade Commission required the sale of Tornier's rights and assets to the total ankle replacements and total silastic toe joint replacements.
5. Wright Medical Group and Tornier have given Integra the total ankle replacement products for up to three years and the total silastic toe joint for one year.